Leila Pirhaji: The medical potential of AI and metabolites
Leila Pirhaji: AI 和代谢产物的医学潜能
Leila Pirhaji uses artificial intelligence for drug discovery and the treatment of metabolic diseases. Full bio
Double-click the English transcript below to play the video.
治疗多种疾病的答案。
to treat many diseases.
could have a significant role
of the population globally,
and leads to liver cancer
而且最终可发展为肝癌
doesn't give us enough information
无法提供足够信息,
还有许多其他分子。
many other molecules in our body.
over 100,000 metabolites.
that is supersmall in their size.
fructose, fats, cholesterol --
in our metabolism.
from both our genes as well as lifestyle.
和我们生活方式的信息。
to find treatments for many diseases.
治疗方法至关重要。
I left medical school,
我因为喜欢数学
algorithms to analyze biological data.
用于分析生物学数据的算法。
the metabolites in our body,
描述疾病中的代谢物变化,
how they are changed in a disease
changes to treat them.
has done this before:
以前为何没人做这件事了:
we can measure their molecular mass
10 molecules with the exact same mass,
可能有 10 种之多,
identify all of them,
which could take decades
这可能需要几十年、
intelligence, or AI, platform, to do that.
人工智能(AI)平台,
information about metabolites
包含代谢物现有信息
with other molecules.
组合成了一个大型网络,
as a meganetwork.
而产生变化的代谢物的质量。
that are changed in a disease.
we don't know exactly what they are.
我们并不知道是什么代谢物。
either the glucose, galactose or fructose.
可以是葡萄糖、半乳糖或果糖,
all these ambiguities.
考虑了所有这些可能。
are connected to each other
what each metabolite mass is,
每个代谢物的质量,
可能是葡萄糖,
and other metabolites
of disease mechanisms
effective therapeutics to target that.
针对该疾病的有效疗法。
to bring this technology to the market
一家初创公司,
进而影响人们的生活。
are working to discover
that metabolites are key drivers for,
by accumulation of fats,
of metabolites in the liver.
it's a huge epidemic with no treatment.
尚无有效疗法。
is just one example.
hundreds of other diseases
data about metabolites
how changes in metabolites
smarter and smarter
for the right patients.
ABOUT THE SPEAKER
Leila Pirhaji - Biotech entrepreneurLeila Pirhaji uses artificial intelligence for drug discovery and the treatment of metabolic diseases.
Why you should listen
Leila Pirhaji is the founder of ReviveMed, an AI platform that can quickly and inexpensively characterize large numbers of metabolites (small molecules like glucose or cholesterol) from the blood, urine and tissues of patients. This allows for the detection of molecular mechanisms that lead to disease and the discovery of drugs that target these disease mechanisms.
Leila Pirhaji | Speaker | TED.com